AMAT
42
4
EXR
42
9
NWS
69
-4
SLG
53
-4
SYY
43
-4
WHR
65
-5
GWW
55
-2
GOOGL
66
-6
ROP
51
-5
RRC
53
-5
A
44
-4
WBA
57
-6
NUE
37
-3
DE
55
2
EA
44
-5
BEN
41
-3
MHK
25
-5
SIG
50
-4
SO
48
4
WAT
55
-2
AMAT
42
4
EXR
42
9
NWS
69
-4
SLG
53
-4
SYY
43
-4
WHR
65
-5
GWW
55
-2
GOOGL
66
-6
ROP
51
-5
RRC
53
-5
A
44
-4
WBA
57
-6
NUE
37
-3
DE
55
2
EA
44
-5
BEN
41
-3
MHK
25
-5
SIG
50
-4
SO
48
4
WAT
55
-2
Financhill
Back

Sage Therapeutics Stock Price Chart

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
32

SAGE
Sage Therapeutics

Last Price:
5.03
Seasonality Move:
3.43%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight selling pressure.

Sage Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.54 Sell
20-day SMA: 5.44 Sell
50-day SMA: 6.16 Sell
200-day SMA: 10.55 Sell
8-day EMA: 5.47 Sell
20-day EMA: 5.58 Sell
50-day EMA: 6.15 Sell
200-day EMA: 11.05 Sell

Sage Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 40.43 Sell
Chaikin Money Flow: -28443 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.11 - 5.73) Sell
Bollinger Bands (100): (5.74 - 8.54) Sell

Sage Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sage Therapeutics Stock

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 5.27 while SAGE 8-day simple moving average is 5.54, which is a Sell signal.
  • The stock price of SAGE is 5.27 while Sage Therapeutics 20-day SMA is 5.44, which makes it a Sell.
  • Sage Therapeutics 50-day simple moving average is 6.16 while SAGE share price is 5.27, making it a Sell technically.
  • SAGE stock price is 5.27 and Sage Therapeutics 200-day simple moving average is 10.55, creating a Sell signal.

SAGE Technical Analysis vs Fundamental Analysis

Sell
32
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics a Buy or a Sell?

  • Sage Therapeutics stock is rated a Sell
    The current Sage Therapeutics [SAGE] share price is $5.27. The Score for SAGE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.

Sage Therapeutics Stock Info

Market Cap:
322.38M
Price in USD:
5.27
Share Volume:
1.17M

Sage Therapeutics 52-Week Range

52-Week High:
28.26
52-Week Low:
4.62
Sell
32
Sage Therapeutics (SAGE) is a Sell

Sage Therapeutics Share Price Forecast

Is Sage Therapeutics Stock a Buy?

  • Sage Therapeutics share price is 5.27 while SAGE 8-day exponential moving average is 5.47, which is a Sell signal.
  • The stock price of SAGE is 5.27 while Sage Therapeutics 20-day EMA is 5.58, which makes it a Sell.
  • Sage Therapeutics 50-day exponential moving average is 6.15 while SAGE share price is 5.27, making it a Sell technically.
  • SAGE stock price is 5.27 and Sage Therapeutics 200-day simple moving average is 11.05, creating a Sell signal.

Fundamental Analysis of Sage Therapeutics

Is Sage Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.

Technical Analysis of Sage Therapeutics

Should I short Sage Therapeutics stock?

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.